THE Vaxelis paediatric hexavalent vaccine is now available on the National Immunisation Program (NIP).
Vaxelis is indicated for primary vaccination in infants from six weeks of age, helping to provide protection against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b (Hib).
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Jul 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
